Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Andersen

Showing results (11-20 of 241) with videos related to

Pageof 25
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 24, 2006
Corticomotoneuronal dysfunction in ALS patients with different SOD1 mutationsHeather G Stewart, Peter M Andersen, Andrew Eisen, et al.
Acta Neuropathologica Communications|January 27, 2016
Low autophagy capacity implicated in motor system vulnerability to mutant superoxide dismutaseEiichi Tokuda, Thomas Brännström, Peter M Andersen, et al.
Journal of Neurochemistry|January 14, 2011
Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patientsPer Zetterström, Peter M Andersen, Thomas Brännström, et al.
Acta Neuropathologica|February 3, 2011
Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosisKarin Forsberg, Peter M Andersen, Stefan L Marklund, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
Screening of hypoxia-inducible genes in sporadic ALSSimon Cronin, Matthew J Greenway, Peter M Andersen, et al.
Plos One|May 26, 2017
Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patientsChristian Burkhardt, Christoph Neuwirth, Andreas Sommacal, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 4, 2013
Progressive aphasia as the presenting symptom in a patient with amyotrophic lateral sclerosis with a novel mutation in the OPTN geneDavid Czell, Peter M Andersen, Christoph Neuwirth, et al.
Human Molecular Genetics|June 2, 2009
Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human diseaseMercedes Prudencio, P John Hart, David R Borchelt, et al.
Journal of the Neurological Sciences|July 29, 2008
Association of APOE with age at onset of sporadic amyotrophic lateral sclerosisHenrik Zetterberg, Johan Jacobsson, Lars Rosengren, et al.
Human Mutation|July 4, 2012
ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis geneticsOlubunmi Abel, John F Powell, Peter M Andersen, et al.
Pageof 25

Showing results (11-20 of 241) with videos related to

Sort By:
Pageof 25
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 24, 2006
Corticomotoneuronal dysfunction in ALS patients with different SOD1 mutationsHeather G Stewart, Peter M Andersen, Andrew Eisen, et al.
Acta Neuropathologica Communications|January 27, 2016
Low autophagy capacity implicated in motor system vulnerability to mutant superoxide dismutaseEiichi Tokuda, Thomas Brännström, Peter M Andersen, et al.
Journal of Neurochemistry|January 14, 2011
Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patientsPer Zetterström, Peter M Andersen, Thomas Brännström, et al.
Acta Neuropathologica|February 3, 2011
Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosisKarin Forsberg, Peter M Andersen, Stefan L Marklund, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
Screening of hypoxia-inducible genes in sporadic ALSSimon Cronin, Matthew J Greenway, Peter M Andersen, et al.
Plos One|May 26, 2017
Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patientsChristian Burkhardt, Christoph Neuwirth, Andreas Sommacal, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 4, 2013
Progressive aphasia as the presenting symptom in a patient with amyotrophic lateral sclerosis with a novel mutation in the OPTN geneDavid Czell, Peter M Andersen, Christoph Neuwirth, et al.
Human Molecular Genetics|June 2, 2009
Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human diseaseMercedes Prudencio, P John Hart, David R Borchelt, et al.
Journal of the Neurological Sciences|July 29, 2008
Association of APOE with age at onset of sporadic amyotrophic lateral sclerosisHenrik Zetterberg, Johan Jacobsson, Lars Rosengren, et al.
Human Mutation|July 4, 2012
ALSoD: A user-friendly online bioinformatics tool for amyotrophic lateral sclerosis geneticsOlubunmi Abel, John F Powell, Peter M Andersen, et al.
Pageof 25